Edwards Lifesciences
568 hedge funds and large institutions have $14.6B invested in Edwards Lifesciences in 2015 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 211 increasing their positions, 198 reducing their positions, and 63 closing their positions.
80% more funds holding in top 10
Funds holding in top 10: 10 → 18 (+8)
67% more call options, than puts
Call options by funds: $129M | Put options by funds: $77.2M
20% more capital invested
Capital invested by funds: $12.2B → $14.6B (+$2.41B)
13.84% more ownership
Funds ownership: 478.76% → 492.61% (+14%)
7% more repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 198
10% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 63
2% less funds holding
Funds holding: 578 → 568 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$299M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$192M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$141M |
| 4 |
FAM
Fred Alger Management
New York
|
+$139M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$102M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$161M |
| 2 |
GIM
Generation Investment Management
London,
United Kingdom
|
-$73.3M |
| 3 |
Bank of New York Mellon
New York
|
-$71.8M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$71M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$52.1M |
EW Hedge Fund Activity: Q3 2015 in Review
568 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2015, worth a combined $14.6B — up 20% from $12.2B a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of EW and 57 opened new positions — a net loss of 6 holders — while 198 trimmed existing stakes and 211 added.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $299M. The largest seller was Wellington Management Group, cutting an estimated $161M.
- 568 institutional investors held Edwards Lifesciences (EW) as of Q3 2015, down from 578 in Q2 2015.
- Funds reported $14.6B of Edwards Lifesciences stock for Q3 2015, up 20% quarter-over-quarter.
- 57 funds opened new Edwards Lifesciences positions in Q3 2015 and 63 closed out, a net change of -6 holders.
- The largest Edwards Lifesciences buyer in Q3 2015 was Winslow Capital Management, an estimated $299M added.
- The largest Edwards Lifesciences seller in Q3 2015 was Wellington Management Group, an estimated $161M sold.
Based on aggregated 13F filings for Q3 2015.